Cite
HARVARD Citation
Pai, R. et al. (n.d.). P395 Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn's disease. Journal of Crohn's and colitis. pp. S404-S406. [Online].